Horizon Discovery - CHOSOURCE™ expression platform
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

XPhyto Completes Strategic Acquisition of 3a-diagnostics GmbH

Monday, December 06, 2021

XPhyto Therapeutics Corp is pleased to announce that the acquisition of adiagnostics GmbH a first announced July is now complete The strategic acquisition of a is a transformative step in XPhytos commercial strategy said Peter Damouni XPhyto direct...

Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in countries accepting the CE Mark to enable rapid differentiation of viral respiratory infections

Monday, December 06, 2021

Roche announced its plans to launch the SARSCoV Flu AB Rapid Antigen Test for professional use in markets accepting the CE Mark by the beginning of January Roche also intends to file for Emergency Use Authorization EUA to the US Food and Drug Admini...

CbdMD Therapeutics Announces Human Clinical Study In Collaboration With the University of South Carolina

Friday, December 03, 2021

CbdMD Inc one of the leading and most highly trusted and recognized cannabidiol CBD brands announced today that it has commenced a preclinical human study with researchers at the University of South Carolina The study will explore the effects of cbdM...

WuXi STA Forms Strategic Partnership with Coherent Biopharma

Thursday, December 02, 2021

WuXi STA a subsidiary of WuXi AppTec and Coherent Biopharma announced the signing of a strategic partnership agreement According to the agreement WuXi STA will become the preferred CDMO partner and provide Coherent Biopharma with integrated CMC serv...

ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors

Thursday, December 02, 2021

ITM Isotope Technologies Munich SE a leading radiopharmaceutical biotech company and Navigo Proteins GmbH a premier protein engineering company developing optimized scaffold proteinbased affinity ligands called Affilin molecules from its Precision Ta...

Chemomab Announces FDA Clearance of Its IND Application for CM-101, a First-In-Class CCL24 Neutralizing Antibody for the Treatment of Primary Sclerosing Cholangitis

Thursday, December 02, 2021

Chemomab Therapeutics Ltd a clinicalstage biotech company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need today announced that the US Food and Drug Administration FDA has...

Clarity and Cardinal Health enter into Agreement for Targeted Copper Theranostics

Thursday, December 02, 2021

Clarity Pharmaceuticals a clinicalstage radiopharmaceutical company developing nextgeneration products to address the growing needs in oncology and Cardinal Health NYSE CAH are pleased to announce that the companies have entered into an agreement cov...

Roche completes purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases

Wednesday, December 01, 2021

Roche announced it has completed its share purchase agreement to acquire percent of the outstanding shares of TIB Molbiol Group TIB Molbiol will continue to operate as a subsidiary within the Diagnostics division Roche and TIB Molbiol will build on...

Teva Announces Launch of an Authorized Generic of Epiduo® Forte Gel (adapalene and benzoyl peroxide gel 0.3%/2.5%), in the U.S.

Wednesday, December 01, 2021

Teva Pharmaceuticals a US affiliate of Teva Pharmaceutical Industries Ltd today announced the launch of an authorized generic of Epiduo Forte Gel adapalene and benzoyl peroxide gel in the United States Adapalene and benzoyl peroxide gel is a topica...

Vaxart Announces Acquisition of Second GMP Manufacturing Facility

Wednesday, December 01, 2021

Vaxart Inc has entered into an agreement with Kindred Bioscience Inc KindredBio for the purchase of KindredBios manufacturing equipment and sublease of its GMP Good Manufacturing Practices manufacturing facility in Burlingame California giving Vaxart...

Surface Oncology Announces FDA Clearance of IND Application for GSK4381562, a Novel Antibody Targeting PVRIG

Wednesday, December 01, 2021

Surface Oncology a clinicalstage immunooncology company developing nextgeneration immunotherapies that target the tumor microenvironment today announced that the US Food and Drug Administration FDA has cleared the Investigational New Drug Application...

Treadwell Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study of TTK inhibitor, CFI-402257

Tuesday, November 30, 2021

Treadwell Therapeutics a clinical stage biotechnology company developing novel therapeutics for highly aggressive cancers today announced that the US Food and Drug Administration FDA has approved its Investigational New Drug IND application to evalua...

ATyr Pharma and FUJIFILM Diosynth Biotechnologies Announce Manufacturing Agreement for aTyr’s Lead Therapeutic Candidate ATYR1923

Tuesday, November 30, 2021

ATyr Pharma Inc a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways and FUJIFILM Diosynth Biotechnologies a leading contract development and manufacturing organization CDMO for...

Allakos Announces Expansion of Lirentelimab Development into Atopic Dermatitis, Chronic Spontaneous Urticaria and Asthma

Tuesday, November 30, 2021

Allakos Inc a biotechnology company developing lirentelimab AK for the treatment of eosinophil and mast cellrelated diseases today announced it has initiated a randomized doubleblind placebocontrolled Phase clinical trial of subcutaneous SC lirentel...

Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19

Monday, November 29, 2021

Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID Treatment Trial ACTT using its proprietary Advantage eClinical system The ACTT trial assessed the efficacy and safety of interfer...

Relief Reports that its U.S. Collaboration Partner has Identified a Significantly Higher Likelihood of Surviving and Recovering from Critical COVID-19

Monday, November 29, 2021

RELIEF THERAPEUTICS Holding SA a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need reported today that the parent company of its collaboration partner NRx Pharmaceuticals Inc Nasdaq NR...

Avacta Announces FDA Approval of its Investigational New Drug (IND) Application for AVA6000

Monday, November 29, 2021

Avacta Group plc a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer and preCISION platforms is pleased to announce that the US Food and Drug Administration FDA h...

Celularity Announces FDA Clearance of Investigational New Drug Application (IND) for Natural Killer Cell Therapy CYNK-101 in First-line Advanced Her2/neu Positive Gastric

Monday, November 29, 2021

Celularity Inc a clinicalstage biotechnology company developing placentalderived allogeneic cell therapies today announced the US Food and Drug Administration FDA has cleared its Investigational New Drug IND application for the use of CYNK in combina...

Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001

Monday, November 29, 2021

Valneva SE a specialty vaccine company and IDT Biologika today announced their collaboration for the production of Valnevas inactivated COVID vaccine candidate VLA This follows last weeks announcement that Valneva signed an Advance Purchase Agreement...

Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma

Monday, November 29, 2021

Todos Medical Ltd a comprehensive medical diagnostics and related solutions company today announced it has entered into a binding agreement to acquire all CL protease biologyrelated assets owned by NLC Pharma and form a majorityowned subsidiary calle...

OriCiro Genomics Launches New enzymatic DNA synthesis tool for commonly used vectors

Monday, November 29, 2021

OriCiro Genomics Inc a pioneer in cellfree synthesis and amplification of genomescale large DNA for advanced therapeutics and synthetic biology today announced the launch of OriCiro CellFree Switching systemIn the biological sciences cellbased clonin...

Philogen Announces New Collaboration With Janssen To Discover Small Molecule Therapeutics

Wednesday, November 24, 2021

Philogen SpA a clinicalstage biotechnology company focused on antibody and small moleculebased targeted therapeutics today announces that its whollyowned Swiss subsidiary Philochem AG has entered into a new collaboration and option agreement with Jan...

Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals

Wednesday, November 24, 2021

Supernus Pharmaceuticals Inc today announced that it has successfully completed its previously announced acquisition of Adamas Pharmaceuticals Inc Adamas fits squarely within our corporate development strategy adding a latestage commercial product wi...

Eppendorf donates 20,000 euros to the EMBL to promote women working in science

Tuesday, November 23, 2021

Eppendorf SE donated euros to the European Molecular Biology Laboratory EMBL during an online presentation ceremony The funds are for the EMBL project Advancement of Women in Science which enables women scientists to begin managerial careers in scie...

Tonix Pharmaceuticals Announces FDA Clearance of the IND for Potentiated Intranasal Oxytocin (TNX-1900) for the Prevention of Migraine Headache in Chronic Migraineurs

Tuesday, November 23, 2021

Tonix Pharmaceuticals Holding Corp a clinicalstage biopharmaceutical company today announced the US Food and Drug Administration FDA has cleared the Investigational New Drug IND Application to support the initiation of a Phase study of TNX intranasa...

Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory

Tuesday, November 23, 2021

Takeda Pharmaceutical Company Limited today announced that the US Food and Drug Administration FDA has approved LIVTENCITY maribavir for the treatment of adults and pediatric patients years of age or older and weighing at least kg with posttranspla...

BioCorRx Acquires Intellectual Property for Drug Delivery

Monday, November 22, 2021

BioCorRx Inc a developer and provider of innovative treatment programs for substance abuse and related disorders today announced that the Company has acquired a patent application from Calista Therapeutics The current application was filed with the...

Decibel Therapeutics Announces Extension of Research Term under Strategic Collaboration with Regeneron to Discover and Develop Gene Therapies for Hearing Loss

Monday, November 22, 2021

Decibel Therapeutics a clinicalstage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance today announced that Regeneron has extended the research term of its collaboration...

Neurocrine Biosciences and Sosei Heptares Announce Collaboration to Develop Novel Muscarinic Receptor Agonists for Schizophrenia and Other Neuropsychiatric Disorders

Monday, November 22, 2021

Neurocrine Biosciences Inc and Sosei Group Corporation announce the signing of a strategic collaboration and licensing agreement to develop novel muscarinic receptor agonists which Neurocrine Biosciences intends to study in the treatment for schizoph...

BiVictriX and Abzena Collaborate to Manufacture Antibody-Drug Conjugates

Friday, November 19, 2021

BiVictriX Therapeutics plc an emerging biotechnology company applying a novelapproach to develop next generation cancer therapies using insights derived from frontline clinical experienceis pleased to announce a collaboration to manufacture BiVictriX...

Latest Issue
Get instant
access to our latest e-book
Saving Money, Saving Time In Pharma Operations Eppendorf SE || LAB Channel Catalent  Asia-Pacific Clinical Supply Solutions SGS - Health Science Horizon - CHOSOURCE advances biotherapeutic production MasterControl - The Never-Normal Future of Manufacturing Medical Fair Thailand 2022 Meco - 90 years